tirzepatide news september 27 2025 US pharmaceutical giant Eli Lilly's weight loss drug Mounjaro (tirzepatide) records Rs 80 crore in revenue in September, making it the second-most sold drug by value in India. The top-selling drug for Eli Lilly gets nod to

Strained fermented yogurt and kefir sit right in that sweet spot

People with diabetes, kidney disease, gallbladder or pancreatic disorders, cardiovascular disease, hormone-sensitive conditions or a history of certain cancers should exercise particular caution

It's hard to believe, but demand for GLP-1 weight loss drugs is almost certain to explode in 2026 even more so than this year, as the first pill versions hit the market and prices start coming down.

Norwood, R

Given that the effect of most antidiabetic medications on weight loss is dose dependent, every effort should be made to ensure that the patient is titrated appropriately to the adequate doses to maximize treatment benefits